2410018C20Rik Activators
2410018C20Rik Activators encompass a variety of chemical compounds that enhance the functional activity of the protein through distinct signaling pathways and cellular processes. Forskolin, Sildenafil, and IBMX all contribute to higher intracellular levels of cAMP, a secondary messenger that plays a pivotal role in cellular signaling. The increased cAMP levels, achieved either through activation of adenylyl cyclase by Forskolin or inhibition of phosphodiesterases by Sildenafil and IBMX, can lead to the activation of protein kinase A (PKA), which may phosphorylate specific substrates and thereby enhance the activity of 2410018C20Rik. Similarly, the inhibition of various protein kinases by Epigallocatechin gallate could prevent negativeregulatory phosphorylations, thus enhancing pathways that include 2410018C20Rik function. LY294002 and PD98059, by inhibiting PI3K and MEK respectively, can initiate feedback mechanisms that may result in the activation of 2410018C20Rik, highlighting the complex interplay between various signaling molecules and pathways.
Y-27632 and PMA, through their actions on ROCK kinase and PKC respectively, may lead to actin cytoskeletal rearrangements or phosphorylation events that positively influence the activity of 2410018C20Rik, indicating a role for these activators in modulating the protein's function within the cellular context. In a similar vein, the inhibition of p38 MAPK by SB203580 and MEK1/2 by U0126 may shift the equilibrium of cellular signaling in a way that favors the enhancement of 2410018C20Rik activity, assuming its involvement in these pathways. The modulation of intracellular calcium levels by A23187 and Thapsigargin, which act as a calcium ionophore and a SERCA inhibitor respectively, can also activate calcium-dependent signaling pathways that contribute to the functional activation of 2410018C20Rik.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, leading to increased levels of cAMP and cGMP, which may enhance the activity of 2410018C20Rik through cAMP/cGMP-dependent signaling mechanisms. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate inhibits various protein kinases, potentially reducing negative regulatory phosphorylations and enhancing the signaling pathways in which 2410018C20Rik is involved without increasing its expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that may lead to activation of 2410018C20Rik by modulating downstream signaling pathways, such as AKT, which could result in feedback mechanisms enhancing 2410018C20Rik activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which may result in the activation of 2410018C20Rik through indirect effects on the MAPK/ERK pathway, altering its activity by modulating the pathway's output. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK kinase, which modulates actin cytoskeleton dynamics. This may indirectly enhance the function of 2410018C20Rik if it is involved in signaling pathways that are regulated by actin cytoskeletal rearrangements. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, and by inhibiting p38, it may shift the balance of cellular signaling to enhance the pathways that activate 2410018C20Rik, if 2410018C20Rik is a part of these pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels. This can enhance the function of 2410018C20Rik if it is part of calcium-dependent signaling pathways by activating those pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. Elevated calcium may enhance the activity of 2410018C20Rik through activation of calcium-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could enhance the activity of 2410018C20Rik by promoting phosphorylation events within PKC-mediated signaling pathways in which 2410018C20Rik is involved. | ||||||